Malignant (primary) neoplasm, unspecified
A Study of Radiotherapy for Controlling Bleeding Caused by Cancer Tumours
Who can joinAdults
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
AIG HospitalsHyderabad, TelanganaDirections ↗
Registry summary (technical)
Prospective Observational Study to Evaluate the Role of HAEMOstatic RADiotherapy for reducing Tumour Related Bleeding in Cancer Patients - HAEMORAD
Sponsor: AIG Hospitals
CTRI/2026/10/119100 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 5 Oct 2026 · read by us 5 Nov 2026